Literature DB >> 18210743

Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.

David L Vesely1, Brian A Vesely, Ehrentraud J Eichelbaum, Ying Sun, Abdel A Alli, William R Gower.   

Abstract

BACKGROUND: Four cardiac hormones i.e. atrial natriuretic peptide (ANP), vessel dilator, long acting natriuretic peptide (LANP) and kaliuretic peptide have anticancer effects in vitro.
MATERIALS AND METHODS: These four cardiac hormones were infused subcutaneously for 28 days with weekly fresh hormones at 3 nM min(-1) kg(-1) body weight in athymic mice bearing human breast adenocarcinomas.
RESULTS: Vessel dilator, LANP, kaliuretic peptide and ANP eliminated 67%, 50%, 67% and 33% of the HTB-132 human breast adenocarcinomas. LANP eliminated 100% and vessel dilator 1/3 of CRL-2327 breast adenocarcinomas. There was no recurrence of the breast cancers in the primary site and no metastasis except in the ANP-treated group in one year post-treatment. The natriuretic peptide receptors-A and -C were decreased 50% and 31%, respectively, in metastatic versus primary ANP-treated breast adenocarcinomas.
CONCLUSION: Four cardiac hormones eliminate up to two-thirds of human breast adenocarcinomas in athymic mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18210743

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  5 in total

1.  Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones.

Authors:  Meghan L Lane; Chelsea D Frost; Jennifer P Nguyen; William P Skelton; Michelle Skelton; David L Vesely
Journal:  Mol Cell Biochem       Date:  2012-09-11       Impact factor: 3.396

2.  Cardiac hormones are potent inhibitors of secreted frizzled-related protein-3 in human cancer cells.

Authors:  William P Skelton; Michelle Skelton; David L Vesely
Journal:  Exp Ther Med       Date:  2012-11-12       Impact factor: 2.447

3.  Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways.

Authors:  David L Vesely
Journal:  Cancers (Basel)       Date:  2011-03-08       Impact factor: 6.639

4.  Serum atrial natriuretic peptide: a suspected biomarker of breast cancer.

Authors:  Maha E Houssen; Hayam F Ghazy; Kamel Farag; Mona Abo Bakr El-Hussiny; Mohamed A El Ghaffar; Sahar Alsayed Mohamed Alsayed; Omar Farouk
Journal:  Contemp Oncol (Pozn)       Date:  2017-03-22

Review 5.  Modified natriuretic peptides and their potential roles in cancer treatment.

Authors:  Mengjiao Xu; Xingzhu Liu; Ping Li; Yadong Yang; Wenyuan Zhang; Siyu Zhao; Ying Zeng; Xile Zhou; Ling-Hui Zeng; Geng Yang
Journal:  Biomed J       Date:  2021-07-06       Impact factor: 7.892

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.